Accelevir performs virus neutralization assays to evaluate antibody or antiviral efficacy against HIV, RSV, influenza, and other pathogens.
- Pseudovirus-Based Neutralization – For high-throughput, BSL-2-compatible workflows.
- Live Virus Neutralization – In BSL-2+ containment for clinically relevant virus strains.
- Quantitative Readouts – Reporter-based or plaque-reduction methods for precise potency measurement.
- Custom Assay Design – Matching strain, variant, and species requirements for each program.